Age

18–75

Sex

FEMALE

Healthy volunteers

Not accepted

Patients with primary gynecological malignant tumor confirmed by histopathology
Women aged 18-75
The expected survival time is greater than 12 weeks
KPS \> 60, ECOG score is 0-2
All subjects voluntarily joined this study with informed consents, and had good compliance of follow-up

Pregnant and lactating women
Suffering from other malignant tumors in the past 5 years
Patients who are not suitable for this study according to the investigator's judgment

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China